Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E26.99 EPS (ttm)2.68 Insider Own1.70% Shs Outstand47.36M Perf Week-0.32%
Market Cap3.43B Forward P/E18.42 EPS next Y3.93 Insider Trans-30.88% Shs Float46.54M Perf Month-5.13%
Income127.50M PEG3.43 EPS next Q0.97 Inst Own98.90% Short Float4.24% Perf Quarter-5.65%
Sales1.32B P/S2.60 EPS this Y25.60% Inst Trans0.69% Short Ratio3.91 Perf Half Y12.17%
Book/sh14.19 P/B5.10 EPS next Y9.35% ROA6.80% Target Price75.17 Perf Year34.94%
Cash/sh3.52 P/C20.54 EPS next 5Y7.88% ROE18.80% 52W Range52.02 - 84.69 Perf YTD13.67%
Dividend- P/FCF19.26 EPS past 5Y9.40% ROI9.00% 52W High-14.58% Beta1.20
Dividend %- Quick Ratio2.00 Sales past 5Y2.10% Gross Margin36.70% 52W Low39.06% ATR1.54
Employees7900 Current Ratio2.30 Sales Q/Q7.00% Oper. Margin15.50% RSI (14)45.75 Volatility1.53% 2.07%
OptionableYes Debt/Eq1.18 EPS Q/Q-2.90% Profit Margin9.60% Rel Volume0.80 Prev Close73.55
ShortableYes LT Debt/Eq1.14 EarningsApr 29 AMC Payout0.00% Avg Volume505.16K Price72.34
Recom2.70 SMA201.53% SMA50-4.76% SMA2006.41% Volume402,601 Change-1.65%
May-04-15Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $88
Apr-24-15Reiterated Barclays Equal Weight $55 → $60
Feb-12-15Reiterated Deutsche Bank Hold $63 → $77
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Jul-14-11Initiated BB&T Capital Mkts Buy $47
May-05-11Reiterated UBS Neutral $40 → $42
Jan-06-11Downgrade Deutsche Bank Buy → Hold $37 → $37
May-12-10Upgrade Robert W. Baird Neutral → Outperform $37
Jan-07-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
Nov-09-09Downgrade Barclays Capital Overweight → Equal Weight
May-13-09Initiated Deutsche Securities Hold
Apr-20-09Downgrade Jefferies & Co Buy → Hold $33
Feb-11-09Reiterated Jefferies & Co Buy $31 → $33
Feb-05-09Reiterated Barclays Capital Overweight $42 → $38
Jan-30-09Downgrade UBS Neutral → Sell
May-27-15 11:59AM  Jefferies Boosts Targets Across Pharmaceutical Service Stocks
May-26-15 09:00AM  Carl Appoints Industry Expert Bryan Segal to the Board of Directors Marketwired
May-11-15 11:50AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-04-15 08:12PM  10-Q for Charles River Laboratories International, Inc. at Company Spotlight
04:54PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences at noodls
04:30PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences Business Wire
06:35AM  Charles River upgraded by Sun Trust Rbsn Humphrey
Apr-30-15 09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today -9.30%
06:10AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
Apr-29-15 05:17PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations at noodls
04:39PM  Charles River misses Street 1Q forecasts
04:30PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations Business Wire
07:07AM  Q1 2015 Charles River Laboratories International Inc Earnings Release - After Market Close
Apr-27-15 06:03PM  Charles River Laboratories Int'l, Inc. -- Moody's affirms Charles River's Ba2 CFR; changes outlook to positive at Moody's
09:02AM  Jefferies Previews Booming Biotech Earnings
Apr-22-15 04:31PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obli
Apr-16-15 09:00AM  Carl Enters Into Letter of Intent for the Purchase of FlowWorks Inc. Marketwired
Apr-09-15 09:32AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call at noodls
09:00AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call Business Wire
Mar-26-15 08:25AM  Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More at 24/7 Wall St.
Mar-11-15 04:06PM  Teachers adds a new stake in PRA Health Sciences
Mar-09-15 07:31PM  Charles River Laboratories to Present at March Investor Conferences at noodls
Mar-02-15 08:00AM  Charles River Laboratories to Present at March Investor Conferences Business Wire
Feb-27-15 05:36PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-26-15 09:00AM  Carl Appoints New President, Chief Executive Officer Marketwired
Feb-25-15 05:03PM  CFO Moves: Charles River Laboratories International, PrairieSky Royalty, SuperGroup at The Wall Street Journal
Feb-24-15 05:06PM  Charles River Laboratories Announces Planned Management Changes at noodls
04:30PM  Charles River Laboratories Announces Planned Management Changes Business Wire
01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
Feb-19-15 07:07PM  10-K for Charles River Laboratories International, Inc. Company Spotlight
Feb-17-15 03:32PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-11-15 06:00PM  Cramer shifts his attention overseas CNBC
04:15PM  Charles River Laboratories to Present at Leerink Global Healthcare Conference Business Wire
09:54AM  Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog Zacks
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
06:02AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
Feb-10-15 04:48PM  Charles River tops Street 4Q forecasts AP
04:30PM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance Business Wire
07:07AM  Q4 2014 Charles River Laboratories International Inc Earnings Release - After Market Close CCBN
Feb-05-15 09:00AM  Carl Subsidiary Hires Chief Technology Officer Marketwired
Jan-26-15 04:15PM  Charles River Laboratories Schedules Fourth-Quarter 2014 Earnings and 2015 Guidance Release and Conference Call Business Wire
Jan-15-15 02:35PM  Quintiles chief looks to grab market share with LabCorp-Covance deal at American City Business Journals
06:00AM  Jim Cramer's Top Stock Picks: MNST ESPR CRL at TheStreet
Jan-14-15 08:22PM  Jim Cramer's 'Mad Money' Recap: Will You Still Hate the Markets Tomorrow? at TheStreet
07:10PM  Cramer Remix: Coke, Pepsi or Monster? at CNBC
Jan-12-15 08:00AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-11-14 07:38AM  Cancer Genetics (CGIX) Looks Good: Stock Rises 8% Zacks
Dec-02-14 09:21AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in EDGAR Online
Nov-12-14 07:57AM  Intrexon (XON) Looks Good: Stock Moves 11% Higher Zacks
Nov-10-14 04:42PM  How Much to End a Marriage? Almost $1 Billion For Harold Hamm at Barrons.com
Nov-04-14 06:03AM  Strength Seen in Covance (CVD): Stock Surges 25.9% Zacks
Nov-03-14 11:00AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Nov-01-14 08:07PM  10-Q for Charles River Laboratories International, Inc. Company Spotlight
Oct-30-14 08:11PM  Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong at TheStreet
07:49PM  Cramer Remix: Apologies owed on Wall Street at CNBC
02:52PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11:30AM  Charles River (CRL) Beats on Q3 Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
Oct-29-14 06:45PM  Charles River beats Street 3Q forecasts AP
04:42PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:05PM  Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations Business Wire
02:15PM  Express Scripts Reports In-Line Q3 Earnings, Narrows View Zacks
11:00AM  McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance Zacks
07:07AM  Q3 2014 Charles River Laboratories International Inc Earnings Release - After Market Close CCBN
Oct-28-14 07:16AM  Why Earnings Season Could Be Great for Charles River Laboratories International (CRL) Zacks
Oct-27-14 11:40AM  Omnicare Beats on Q3 Earnings and Sales, Outlook Positive Zacks
Oct-24-14 09:10AM  Healthways Earnings and Revenues in Line, View Maintained Zacks
Oct-08-14 04:15PM  Charles River Laboratories Schedules Third-Quarter 2014 Earnings Release and Conference Call Business Wire
Sep-09-14 09:08AM  Charles River (CRL) Stock: Moving Average Crossover Alert Zacks
Sep-08-14 08:00AM  Charles River Laboratories to Present at Morgan Stanley Global Healthcare Conference Business Wire
Sep-04-14 06:53AM  Why Intrexon (XON) Could Be Positioned for a Slump Zacks
Aug-27-14 06:55AM  iKang Healthcare Slumps: KANG Plunges 13.6% in Session Zacks
Aug-26-14 07:06AM  iKang Healthcare Group, Inc. (KANG) Jumps: Stock Surges 10.1% Zacks
Aug-18-14 06:54AM  Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again Zacks
Aug-13-14 06:00AM  Jim Cramer's Top Stock Picks: TSLA TNET CRL at TheStreet
Aug-12-14 08:13PM  Jim Cramer's 'Mad Money' Recap: Stocks That Stand the Test of Time at TheStreet
06:50PM  Cramer: Is Charles River getting ready to run? at CNBC
Aug-08-14 07:30AM  Charles River Laboratories (CRL) Jumps: Stock Moves 5% Higher Zacks
Aug-07-14 01:10PM  Charles River Beats on Q2 Earnings & Revenues, Outlook Upped Zacks +5.04%
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
06:02AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
Aug-06-14 04:40PM  Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations Business Wire
07:07AM  Q2 2014 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
Jul-24-14 09:00AM  Charles River Laboratories to Webcast Investor Meeting Business Wire
Jul-22-14 04:51PM  John Rogers' Ariel Fund Second Quarter 2014 Commentary Gurufocus
Jul-07-14 04:15PM  Charles River Laboratories Schedules Second-Quarter 2014 Earnings Release and Conference Call Business Wire
Jun-05-14 10:30AM  Insider Trading Alert - FWLT, CRL And SAH Traded By Insiders at TheStreet
Jun-02-14 09:33AM  Charles River Laboratories to Present at Jefferies and William Blair Conferences Business Wire
May-20-14 09:37AM  UPDATE: Morgan Stanley Reiterates On Charles River Laboratories Following CEO Conference Call Benzinga
May-12-14 11:29AM  [video] Jim Cramer Says Yahoo Should Buy Yelp With Its Alibaba Payday at TheStreet
May-09-14 12:43PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
May-05-14 04:59PM  Charles River Laboratories to Present at Bairds Growth Stock Conference Business Wire
May-02-14 08:50AM  Charles River Laboratories (CRL) is now in Oversold Territory Zacks
May-01-14 03:41PM  Charles River, PAREXEL lower after peers combine at theflyonthewall.com
02:36PM  Charles River Beats on Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
Apr-30-14 04:49PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:44PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:30PM  Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations Business Wire
10:50AM  Express Scripts Misses Earnings, Guides Low Zacks
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist its clients in supporting the use of research models in drug discovery and development comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target within a cell through delivery of clinical drug candidates; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides non-animal or in vitro methods for lot release testing of medical devices and injectable drugs for endotoxin contamination. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and specific pathogen free fertile chicken eggs and chickens for the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Option Exercise37.925,000189,600105,635May 18 04:11 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale71.061,10078,168100,635May 18 04:13 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale70.513,900274,974101,735May 18 04:11 PM
MASSARO GEORGEDirectorMay 07Sale70.211,36095,48715,120May 08 07:26 AM
CHUBB STEPHEN DDirectorMay 01Sale69.802,000139,59515,534May 05 04:48 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Option Exercise59.4191254,1826,131Mar 06 12:50 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Sale76.5391269,7925,219Mar 06 12:50 PM
CHUBB STEPHEN DDirectorMar 03Sale75.522,000151,04717,854Mar 05 08:17 AM
GILLETT NANCYCorporate Executive VPMar 02Option Exercise59.414,379260,15622,589Mar 03 02:42 PM
FOSTER JAMES CChairman, President and CEOMar 02Option Exercise59.4120,0711,192,418360,333Mar 04 06:34 AM
Kochevar Deborah TurnerDirectorMar 02Sale76.592,600199,1378,770Mar 03 02:59 PM
GILLETT NANCYCorporate Executive VPMar 02Sale76.724,379335,94918,210Mar 03 02:42 PM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.932,036156,625340,262Mar 04 06:39 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.679,483727,051342,298Mar 04 06:36 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.488,552654,091351,781Mar 04 06:34 AM
GILLETT NANCYCorporate Executive VPFeb 27Sale76.952,772213,30619,162Mar 03 11:31 AM
GILLETT NANCYCorporate Executive VPFeb 25Option Exercise37.8417,477661,39639,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 25Option Exercise37.0335,5381,315,972360,083Feb 27 09:41 AM
GELLER JORGCorporate Executive VPFeb 25Option Exercise37.032,863106,01717,820Feb 27 09:33 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale75.964,621351,029355,462Feb 27 09:41 AM
GELLER JORGCorporate Executive VPFeb 25Sale76.793,726286,12614,094Feb 27 09:33 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.8011,477881,47621,934Feb 27 09:57 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.596,000459,53833,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.8611,003845,683324,545Feb 27 09:53 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.7112,914990,641335,548Feb 27 09:51 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.457,000535,142348,462Feb 27 09:44 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.273,532269,39922,805Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 24Option Exercise36.256,987253,27928,319Feb 25 09:34 PM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise36.2524,387884,029364,482Feb 25 05:24 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.2212,433947,582342,178Feb 25 05:28 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.402,083159,145340,095Feb 25 05:29 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.704,800363,364359,682Feb 25 05:24 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.965,071385,217354,611Feb 25 05:26 PM
GILLETT NANCYCorporate Executive VPFeb 24Sale75.741,483112,32727,969Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.301,30199,26014,957Feb 25 09:39 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.1712,061918,65615,558Feb 25 09:34 PM
GELLER JORGCorporate Executive VPFeb 23Option Exercise40.405,502222,28128,373Feb 24 02:22 PM
FOSTER JAMES CChairman, President and CEOFeb 23Option Exercise40.4021,779879,872361,874Feb 25 09:23 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.973,400261,684340,095Feb 25 09:29 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.769,956764,174343,495Feb 25 09:26 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.568,423644,829353,451Feb 25 09:23 AM
GELLER JORGCorporate Executive VPFeb 23Sale76.597,041539,29121,332Feb 24 02:22 PM
FOSTER JAMES CChairman, President and CEOFeb 20Option Exercise58.5870,2294,114,015413,193Feb 24 04:01 PM
MILNE GEORGE M JRDirectorFeb 20Option Exercise61.726,000370,32036,790Feb 23 01:00 PM
MILNE GEORGE M JRDirectorFeb 20Sale75.876,000455,22330,790Feb 23 01:00 PM
FOSTER JAMES CChairman, President and CEOFeb 20Sale75.0070,2295,267,175342,964Feb 24 04:01 PM
FOSTER JAMES CChairman, President and CEOFeb 19Option Exercise58.589,671566,527352,635Feb 20 01:29 PM
FOSTER JAMES CChairman, President and CEOFeb 19Sale75.009,671725,325342,964Feb 20 01:29 PM
CHUBB STEPHEN DDirectorFeb 18Option Exercise61.726,000370,32024,865Feb 19 07:22 AM
CHUBB STEPHEN DDirectorFeb 18Sale73.975,011370,64919,854Feb 19 07:22 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Option Exercise36.925,000184,600109,211Feb 18 02:12 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.722,570189,46922,871Feb 18 01:11 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.7560044,248104,211Feb 18 02:14 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.504,400323,398104,811Feb 18 02:12 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.5414,4301,061,12025,441Feb 18 01:09 PM
Molho DavideCorporate Executive VPFeb 13Option Exercise36.252,40087,00045,704Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.0058243,068574Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.002,400177,60043,304Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Option Exercise36.258,675314,46951,979Feb 17 10:05 AM
GELLER JORGCorporate Executive VPFeb 12Sale73.688,458623,16339,871Feb 17 07:59 AM
Molho DavideCorporate Executive VPFeb 12Sale74.007,418548,9321,156Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Sale74.008,675641,95043,304Feb 17 10:05 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 26Option Exercise37.9210,000379,200114,211Jan 28 02:28 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 26Sale70.0010,000700,000104,211Jan 28 02:28 PM
JOHST DAVID PCorp Executive VPJan 08Option Exercise47.364,737224,344147,686Jan 12 07:18 AM
JOHST DAVID PCorp Executive VPJan 08Sale67.004,737317,379142,949Jan 12 07:18 AM
JOHST DAVID PCorp Executive VPJan 07Option Exercise58.5826,1001,528,938169,049Jan 08 11:16 AM
JOHST DAVID PCorp Executive VPJan 07Sale65.0026,1001,696,500142,949Jan 08 11:16 AM
CHUBB STEPHEN DDirectorDec 01Sale64.442,000128,88118,865Dec 02 02:44 PM
JOHST DAVID PCorp Executive VPNov 28Option Exercise47.366,982330,668149,931Dec 02 08:52 AM
JOHST DAVID PCorp Executive VPNov 28Sale65.346,982456,171142,949Dec 02 08:52 AM
GELLER JORGCorporate Executive VPNov 14Option Exercise58.587,350430,56355,679Nov 17 02:42 PM
GELLER JORGCorporate Executive VPNov 14Sale63.801,740111,01348,329Nov 17 02:44 PM
GELLER JORGCorporate Executive VPNov 14Sale63.575,610356,61950,069Nov 17 02:42 PM
Molho DavideCorporate Executive VPNov 12Option Exercise37.039,360346,60152,664Nov 14 03:14 PM
Molho DavideCorporate Executive VPNov 12Sale64.689,360605,37343,304Nov 14 03:14 PM
REESE C RICHARDDirectorNov 06Option Exercise61.726,000370,32028,790Nov 07 02:20 PM
REESE C RICHARDDirectorNov 06Sale63.395,849370,74322,941Nov 07 02:20 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Option Exercise46.621,00046,6205,607Nov 05 02:37 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Sale64.001,00064,0014,607Nov 05 02:37 PM
GILLETT NANCYCorporate Executive VPNov 03Option Exercise58.5826,7311,565,90256,646Nov 05 12:19 PM
MASSARO GEORGEDirectorNov 03Option Exercise41.6716,710696,33226,220Nov 04 03:33 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Option Exercise52.8636,1001,908,138140,311Nov 04 02:17 PM
Molho DavideCorporate Executive VPNov 03Option Exercise37.0316,402607,36659,706Nov 04 03:24 PM
Molho DavideCorporate Executive VPNov 03Sale64.5416,4021,058,54743,304Nov 04 03:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Sale65.0036,1002,346,500104,211Nov 04 02:17 PM
MASSARO GEORGEDirectorNov 03Sale65.0016,7101,086,15015,510Nov 04 03:33 PM
GILLETT NANCYCorporate Executive VPNov 03Sale64.9135,3312,293,16329,915Nov 05 12:19 PM
GILLETT NANCYCorporate Executive VPOct 30Option Exercise58.581,06962,62239,584Nov 03 10:47 AM
GILLETT NANCYCorporate Executive VPOct 30Sale65.001,06969,48538,515Nov 03 10:47 AM
JOHST DAVID PCorp Executive VPOct 28Option Exercise42.2574,7803,159,360217,729Oct 30 05:04 PM
JOHST DAVID PCorp Executive VPOct 28Sale64.0074,7804,785,920142,949Oct 30 05:04 PM
FOSTER JAMES CChairman, President and CEOOct 21Option Exercise47.7528,9971,384,607379,961Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 21Sale62.0028,9971,797,814350,964Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 03Option Exercise47.68136,6476,515,753487,611Oct 07 02:10 PM
GELLER JORGCorporate Executive VPOct 03Sale61.6089355,00748,329Oct 06 12:44 PM
FOSTER JAMES CChairman, President and CEOOct 03Sale62.00136,6478,472,114350,964Oct 07 02:10 PM
Molho DavideCorporate Executive VPSep 04Option Exercise58.584,900287,04248,204Sep 05 11:24 AM
Molho DavideCorporate Executive VPSep 04Sale61.344,900300,57143,304Sep 05 11:24 AM
MASSARO GEORGEDirectorAug 26Option Exercise28.2910,440295,34826,950Aug 27 03:30 PM